Wantstats
Company ProfilePremium

LEO Pharma A/S

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
LEO Pharma A/S - Healthcare showcase

Year Founded & Workforce

1908

5,820 Employees

Industry

Healthcare

Services

Acne Treatment
L

LEO Pharma A/S Employee Contacts

3 verified contactsNames, job titles, seniority and locations

View Employee Contacts

LEO Pharma A/S Overview

Company Headquarters: Ballerup, Copenhagen, Denmark

Founded: 1908

Workforce: ~5,820

Company Working: LEO Pharma A/S (LEO Pharma) is a global dermatology company. The company develops and markets products for dermatology, bone remodeling thrombosis, and coagulation. It provides products in multiple delivery systems such as topical, injections, and tablets. It operates through six major business segments, including Psoriasis, Eczema /Skin infection, Thrombosis, Acne/Rosacea, Actinic keratosis, and CMOs/Others. The company has a presence in more than 130 countries globally.

Strategy

LEO Pharma A/S focuses on increasing the value of its businesses in the long-term through research & development (R&D) of innovative products. The company strongly emphasizes on mergers & acquisitions for business expansion. It also aims at improving the available products in the market.

Company Snapshot

$1,592.2M

Revenue

5,820

Employees

1908

Founded

Ballerup, Copenhagen, Denmark

Headquarters

SWOT Analysis

Strengths

  • Unique product range
  • Strong global presence
  • Well-developed distribution channel

Weaknesses

  • Major dependency on European market for revenue generation
  • Limited business segments

Opportunities

  • Enhancing the product portfolio by launching new products
  • Opportunity to expand into new areas

Threats

  • Stringent government regulations for product approval

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
July 2019AcquisitionLEO Pharma acquired Bayer’s prescription dermatology business. With this, the company aims to expand its business in Brazil, Austria, and South Africa.

Product Offering

  • LEO Pharma A/S
    • Acne Treatment

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 1,592.2 Mn in 2017 to USD 1,620.1 Mn in 2019.
LEO Pharma A/S — By Business Segment
Series (USD Mn)201720182019
Sales1,592.21,649.21,620.1
R&D238.8296.8372.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →